Preliminary data suggests that Americans who visit hospitals, dialysis centers, or abortion clinics face an elevated risk of their mobile device location being auctioned to third parties.
The Federal Trade Commission recently halted one data company's protocol of monetizing patient movements, effectively ending a vast observational cohort involving hundreds of millions of Americans. However, a peer-reviewed analysis of the broader tech industry indicates the correlation between entering a medical facility and being tracked by unregulated brokers remains robust, though experts caution that more research is needed to prove direct causation between downloading a weather app and losing all medical privacy.
While the data shows a statistically significant link between receiving chemotherapy and your phone broadcasting that fact to marketing firms, we must be careful not to draw premature conclusions about whether this surveillance is harmful.
In the absence of comprehensive federal guidance, several states have initiated localized legislative trials to restrict the sale of this data. Analysts note that these interventions currently suffer from a small sample size, as secondary data brokers frequently bypass state-level protections to harvest the coordinates of individuals seeking reproductive care or addiction treatment.
The NIH has yet to classify unconsented geographic monetization as a formal risk factor for adverse health outcomes. Until a longitudinal study can be completed, health officials advise that patients concerned about their precise coordinates being sold to anonymous buyers should continue attending their medical appointments, while maintaining a healthy dose of caution regarding the clinical efficacy of their smartphone's privacy settings.